Earnings History Data for GeneDx Holdings Corp. (WGS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
GeneDx Holdings Corp.
GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20-02-2024 | AH | WGS | GeneDx Holdings Corp. | 115.19 | -0.59 | -0.60 | 0.00 | GeneDx reports Q4 results [2/20/2024 5:06 PM] |
6.95 | 1.71 (32.63%) |
5.00 | -0.24 (-4.58%) |
1.16 - 17.82 | 711,133 | 160,000 | 11,774 | ||
| 30-10-2023 | AH | WGS | GeneDx Holdings Corp. | 76.29 | -0.82 | -1.18 | -6.60 | GeneDx GAAP EPS of -$1.64 misses by $0.46, revenue of $53M beats by $0.59M [10/30/2023 4:29 PM] |
1.88 | -0.79 (-29.59%) |
2.35 | -0.32 (-11.99%) |
1.84 - 35.31 | 445,414 | 140,000 | 1,267 | ||
| 08-08-2023 | AH | WGS | GeneDx Holdings Corp. | 182.71 | -1.65 | -1.47 | -6.93 | GeneDx GAAP EPS of -$1.84 misses by $0.49, revenue of $48.71M beats by $1.08M [8/8/2023 5:31 PM] |
5.80 | -0.85 (-12.78%) |
7.00 | 0.35 (5.26%) |
5.34 - 81.84 | 108,238 | 70,000 | 12,543 | ||
| 09-05-2023 | AH | After the close (May 9) |
WGS | GeneDx Holdings Corp. | 218.60 | -2.82 | -1.65 | -8.58 | GeneDx GAAP EPS of -$3.04 misses by $0.40, revenue of $43.14M beats by $3.93M [5/9/2023 4:38 PM] |
8.21 | -0.14 (-1.68%) |
8.35 | 0.0 (0.00%) |
7.26 - 81.84 | 154,243 | 140,000 | 335 | |
| 14-03-2023 | AH | After the close (Mar 14) |
WGS | GeneDx Holdings Corp. | 366.47 | N/A | -0.19 | -0.17 | GeneDx reports Q4 results [3/14/2023 4:23 PM] |
0.3488 | 0.0 (-0.26%) |
0.37 | 0.02 (5.80%) |
0.22 - 3.28 | 3,252,411 | 4,720,000 | 3,390 | |